Aldebaran Capital’s Kezar Life Sciences KZR Stock Holding History

Aldebaran Capital’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80,335	Closed	-$596K	–	40
2026 Q1	$596K	Sell	80,335 -295	-0.4%	-$1.92K	0.46%	30
2025 Q4	$507K	Buy	+80,630	New	+$470K	0.45%	26

Aldebaran Capital's KZR Position: Q2 2026 in Review

Aldebaran Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 80,335 shares — an estimated $596K sold.

Aldebaran Capital first reported a position in KZR in Q4 2025 and held it in 2 quarters. The position peaked at $596K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Aldebaran Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Aldebaran Capital sold 80,335 Kezar Life Sciences shares in Q2 2026, an estimated $596K.
Aldebaran Capital first reported a position in Kezar Life Sciences in Q4 2025 and held it in 2 quarters.
Aldebaran Capital's Kezar Life Sciences position peaked at $596K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Aldebaran Capital's 13F filing for Q2 2026, filed 14 Aug 2026.